Fusion gene: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|An article about fusion genes in genetics}} | |||
== | ==Overview== | ||
A '''fusion gene''' is a hybrid gene formed from two previously separate genes. It can occur as a result of [[chromosomal rearrangement]]s such as [[translocation]], [[interstitial deletion]], or [[chromosomal inversion]]. Fusion genes are often associated with [[cancer]] and can be used as [[biomarkers]] for diagnosis and treatment. | |||
Fusion genes are formed through | ==Formation== | ||
Fusion genes are typically formed through the joining of two separate [[gene]]s, which can occur through various mechanisms: | |||
* '''Translocation''': A segment of one chromosome is transferred to another chromosome. | |||
* '''Inversion''': A segment of a chromosome is reversed end to end. | |||
* '''Deletion''': A segment of a chromosome is lost, and the remaining parts are joined together. | |||
These events can lead to the creation of a new gene with novel functions, which can contribute to the development of diseases such as cancer. | |||
== | ==Role in Cancer== | ||
[[File:Gene_Fusion_Types.png|thumb|right|Different types of gene fusions.]] | |||
Fusion genes are frequently found in various types of cancer. They can lead to the production of abnormal [[protein]]s that drive the growth and proliferation of cancer cells. Some well-known examples include: | |||
* '''BCR-ABL''': Found in [[chronic myeloid leukemia]] (CML), resulting from a translocation between chromosomes 9 and 22, known as the [[Philadelphia chromosome]]. | |||
* '''PML-RARA''': Associated with [[acute promyelocytic leukemia]] (APL), resulting from a translocation between chromosomes 15 and 17. | |||
These fusion genes can serve as targets for specific [[targeted therapy|targeted therapies]], such as [[tyrosine kinase inhibitors]] in the case of BCR-ABL. | |||
Fusion genes can be | ==Detection and Diagnosis== | ||
Fusion genes can be detected using various [[molecular biology]] techniques, including: | |||
* '''[[Polymerase chain reaction|PCR]]''': Amplifies specific DNA sequences to detect the presence of fusion genes. | |||
* '''[[Fluorescence in situ hybridization|FISH]]''': Uses fluorescent probes to visualize specific DNA sequences on chromosomes. | |||
* '''[[Next-generation sequencing|NGS]]''': Allows for comprehensive analysis of genetic alterations, including fusion genes. | |||
These techniques are crucial for the accurate diagnosis and classification of cancers, as well as for guiding treatment decisions. | |||
==Therapeutic Implications== | |||
The identification of fusion genes has significant implications for the development of targeted therapies. Drugs that specifically inhibit the activity of proteins produced by fusion genes can be highly effective in treating certain cancers. For example, [[imatinib]] is a drug that targets the BCR-ABL fusion protein in CML, leading to improved patient outcomes. | |||
==Related pages== | |||
* [[Oncogene]] | * [[Oncogene]] | ||
* [[ | * [[Tumor suppressor gene]] | ||
* [[Chromosomal translocation]] | |||
* [[Cancer genomics]] | |||
* [[Chromosomal | |||
* [[ | |||
[[Category:Genetics]] | [[Category:Genetics]] | ||
[[Category:Cancer]] | [[Category:Cancer]] | ||
Latest revision as of 11:16, 15 February 2025
An article about fusion genes in genetics
Overview[edit]
A fusion gene is a hybrid gene formed from two previously separate genes. It can occur as a result of chromosomal rearrangements such as translocation, interstitial deletion, or chromosomal inversion. Fusion genes are often associated with cancer and can be used as biomarkers for diagnosis and treatment.
Formation[edit]
Fusion genes are typically formed through the joining of two separate genes, which can occur through various mechanisms:
- Translocation: A segment of one chromosome is transferred to another chromosome.
- Inversion: A segment of a chromosome is reversed end to end.
- Deletion: A segment of a chromosome is lost, and the remaining parts are joined together.
These events can lead to the creation of a new gene with novel functions, which can contribute to the development of diseases such as cancer.
Role in Cancer[edit]
Fusion genes are frequently found in various types of cancer. They can lead to the production of abnormal proteins that drive the growth and proliferation of cancer cells. Some well-known examples include:
- BCR-ABL: Found in chronic myeloid leukemia (CML), resulting from a translocation between chromosomes 9 and 22, known as the Philadelphia chromosome.
- PML-RARA: Associated with acute promyelocytic leukemia (APL), resulting from a translocation between chromosomes 15 and 17.
These fusion genes can serve as targets for specific targeted therapies, such as tyrosine kinase inhibitors in the case of BCR-ABL.
Detection and Diagnosis[edit]
Fusion genes can be detected using various molecular biology techniques, including:
- PCR: Amplifies specific DNA sequences to detect the presence of fusion genes.
- FISH: Uses fluorescent probes to visualize specific DNA sequences on chromosomes.
- NGS: Allows for comprehensive analysis of genetic alterations, including fusion genes.
These techniques are crucial for the accurate diagnosis and classification of cancers, as well as for guiding treatment decisions.
Therapeutic Implications[edit]
The identification of fusion genes has significant implications for the development of targeted therapies. Drugs that specifically inhibit the activity of proteins produced by fusion genes can be highly effective in treating certain cancers. For example, imatinib is a drug that targets the BCR-ABL fusion protein in CML, leading to improved patient outcomes.
